|
⚲
|
| Keyboard |
| Silberman David
✚
|
|
|---|---|
| CIK # | 0001867998 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001867998] | |
| 4 | [0001867998] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Silberman David | |
| Nasus Pharma Ltd | |
| Compugen Ltd | |
| Oramed Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2024-01-04 | Grant | 136,500 | ||
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2023-05-26 | Grant | 24,500 | ||
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2023-04-17 | Grant | 97,500 | ||
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2022-07-28 | Grant | 39,000 | ||
|
Oramed Pharmaceuticals Inc ORMP
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 32,000 | $0.00 | |
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2022-01-03 | Grant | 19,000 | ||
|
Oramed Pharmaceuticals Inc ORMP
Common Stock
|
2021-09-01 | Grant | 50,000 | $0.00 | |
|
Oramed Pharmaceuticals Inc ORMP
Stock Option (right to buy) · derivative
|
2021-09-01 | Grant | 50,000 | $0.00 |